- 4 of the 11 criteria in the following list are needed to make the diagnosis:
- Malar rash
- Discoid rash
- Photosensitivity rash
- Oral ulcers
- Arthritis
- Serositis
- Neurologic disorders
- Hematologic disorders
- Immunologic disorders
- Renal disorders
- Antinuclear antibodies
Signs and Symptoms
- Systemic:
- Fatigue
- Fever
- Weight loss
- Dyspnea
- Skin:
- Malar rash (butterfly maculopapular facial)
- Discoid rash (raised red patches)
- Photosensitivity rash (subacute cutaneous lupus)
- Bullous rash (large blisters)
- Musculoskeletal:
- Myalgias
- Joint pain
- Arthritis:
- Defined as 2 or more peripheral joints
- Polyarthritis, symmetric, or migratory
- Heart:
- Chest pain
- Pericardial rub
- Murmur
- Vascular:
- Vasculitis
- Thrombosis
- Atherosclerosis
- Peripheral vascular disease
- Lungs:
- Dyspnea
- Tachypnea
- Pleural rub
- Rales
- Nervous system:
- Psychosis/depression
- Headache
- Seizures
- Peripheral neuropathies
- Stroke/cranial nerve deficits
- Cerebritis
- GI:
History
- Symptoms commonly accumulate and exacerbate over years, with flares and remissions. A history of fatigue, rashes, and joint pain may point to the diagnosis
- Patients describe arthralgias out of proportion to physical findings
- Ask about medication use (it is suggested to avoid minocycline in nondrug-induced SLE), sun exposure
Physical Exam
- Check for fever
- Carefully evaluate skin for rashes and vasculitis
Essential Workup
- Thorough history and physical exam needed to distinguish between major and minor flare-ups
- Major flare-ups:
- CBC
- Electrolytes, BUN, creatinine, glucose
- UA
- ESR
- CXR, ECG, and pulse oximetry for cardiorespiratory symptoms
Diagnostic Tests & Interpretation
Lab
- CBC:
- Leukopenia, thrombocytopenia, normochromic normocytic anemia
- Degree of hematologic disorders suggests degree of disease activity
- ESR:
- May be elevated during acute exacerbations
- Not a good indicator of active disease
- CRP
- May also be elevated
- Marked elevation may be a sign of infection
- PTT:
- May be elevated in patients with lupus anticoagulant
- UA:
- Protein (persistent proteinuria >0.5 g/d or 3+ persistently)
- Note that marked proteinuria and reduced GFR may result from either active inflammation or scarred glomeruli
- Casts (red blood cell)
- Hematuria
- WBCs
- Complement levels (C3 and C4):
- Low or high levels often indicate active lupus, particularly lupus nephritis
- Send antinuclear antibody, rheumatoid factor (RF), antistreptolysin O (ASO) titer if diagnosis unclear
- Anti-Sm and anti-dsDNA are diagnostic
- A false-positive Venereal Disease Research Laboratory (VDRL) test is supportive of the diagnosis
- Do not repeatedly check ANAs or other specific antibodies besides anti-dsDNA antibodies because unlikely to change over time and do not correlate with disease activity
- Joint aspirate typically shows fluid with fewer than 3,000 WBCs
- LP if suspicion for meningitis or encephalitis
Imaging
- CXR:
- Pneumonitis
- Pneumonias
- Pleural effusion
- Cardiomegaly
- ECG/echocardiogram
- CT chest:
- Pulmonary embolus
- Pulmonary hemorrhage
- Diffuse alveolar hemorrhage
- CT head for change in mental status or neurologic findings (lupus cerebritis is a diagnosis of exclusion)
Pregnancy Prophylaxis |
- Pregnancy is not recommended during active disease owing to the high risk of spontaneous abortion
- The effect of pregnancy on disease activity is variable
|
Differential Diagnosis
- Hypotension in the known lupus patient may be due to shock from a major flare-up, secondary to acute steroid withdrawal, or the result of sepsis
- Other autoimmune diseases:
- Rheumatic fever
- Rheumatoid arthritis
- Dermatomyositis
- Overlap syndromes
- Skin changes:
- Urticaria
- Erythema multiforme
- Idiopathic thrombocytopenic purpura
- Multiple sclerosis
- Epilepsy
Initial Stabilization/Therapy
ABCs
ED Treatment/Procedures
- Mainstays include NSAIDs, corticosteroids, antimalarials, and immunosuppressive drugs
- Special attention must be given to CNS and renal involvement as well as infections; these are the main determinants of morbidity
- Mild flare-ups - arthralgias, myalgias, fatigue, and rash with possible mild leukopenia:
- NSAIDs (careful with lupus nephritis), acetyl salicylic acid (ASA), topical steroids for rash, sunscreen
- Topical steroids for most cutaneous manifestations
- If not sufficient, begin low-dose Prednisone
- Moderate flare-ups - possibly pleuritic chest pain, joint swelling, and elevated acute phase reactants
- May need short-term increase or a short course of Prednisone
- Major flare-ups - life or organ threatening:
- Methylprednisolone
- Anticoagulation for thrombosis; give blood products early if needed
- Psychotropics for neuropsychiatric symptoms
- Anticonvulsants for seizures
- If poor response, consult rheumatology before starting cytotoxic medications
- Chronically:
- Prednisone
- NSAIDs
- Rheumatologist initiated:
- Belimumab (FDA approved for active, autoantibody positive disease in patients under active treatment, only drug approved for SLE treatment in 60 yr)
- Cyclophosphamide
- Azathioprine
- Methotrexate
- Cyclosporine
- Tacrolimus
- Mycophenolate mofetil (MMF)
- Rituximab
- Hormonal therapy and autologous marrow stem cell transplant are under investigation
Medication
- Methylprednisolone: 15 mg/kg/d IV up to 1 g; consult rheumatologist for peds dosing
- Prednisone: 5-30 mg (peds: <0.5 mg/kg) PO daily for minor flare
- Prednisone: 1-2 mg/kg/d PO for major flares in adults
- Ibuprofen: 800 mg (peds: 5-10 mg/kg) PO t.i.d
Disposition
Admission Criteria
- Patients who have end-organ disease such as renal, cardiac, or CNS involvement
- Thrombocytopenia with hemorrhage, arterial or venous thrombosis
- Consider admission with pericarditis, myocarditis, pleural effusion or infiltrates, and evidence of vasculitis
- Those with severe end-organ or life-threatening manifestations should be admitted to the ICU
- Patients with lupus should be treated as immunocompromised and suspected or diagnosed infections should be treated aggressively
Discharge Criteria
- Patients may be discharged home with mild flare-ups if afebrile, well hydrated, and not ill appearing
- ESR should not be used as disposition criterion as it may be elevated long after a flare-up has subsided
Issues for Referral
Because lupus is a chronic disease, a rheumatologist or knowledgeable primary care physician (PCP) must follow the patient adequately
Follow-up Recommendations
PCPs must educate patients regarding sun protection, immunizations, and lowering risks of atherosclerosis
- BuyonJP. Systemic lupus erythematosus: Clinical and laboratory features. In: KlippelJH, ed. Primer on the Rheumatic Diseases. 13th ed.Atlanta, GA: Arthritis Foundation; 2008:303-318.
- CocaA, SanzI. Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome . Curr Opin Rheumatol. 2012;24:451-456.
- LehrmannJ, SercombeCT. Systemic lupus erythematosus and the vasculitides. Rosen's Emergency Medicine. 7th ed.Philadelphia, PA: Mosby Elsevier; 2010.
- MahieuMA, Strand V, SimonLS, et al. A critical review of clinical trials in systemic lupus erythematosus . Lupus. 2016;25(10):1122-1140.
- WallaceDJ. Overview of the management and prognosis of systemic lupus erythematosus in adults . www.uptodate.com. Accessed June 17, 2019.
The authors gratefully acknowledge John Lemos for his contribution to the previous edition of this chapter.